您当前的位置:
首页 >
文章列表页 >
The clinical interpretation of modified staging system for pancreatic neuroendocrine tumors
更新时间:2025-12-31
    • The clinical interpretation of modified staging system for pancreatic neuroendocrine tumors

    • China Oncology   Vol. 27, Issue 5, Pages: 321-325(2017)
    • DOI:10.19401/j.cnki.1007-3639.2017.05.001    

      CLC:
    • Published Online:14 June 2017

      Published:14 June 2017

    移动端阅览

  • 罗国培, 金凯舟, 程 合. The clinical interpretation of modified staging system for pancreatic neuroendocrine tumors[J]. China Oncology, 2017, 27(5): 321-325. DOI: 10.19401/j.cnki.1007-3639.2017.05.001.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

2820

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Updates on the research and management of pancreatic neuroendocrine neoplasm in 2021
Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis
Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study
Impact of radiation-induced lymphopenia on prognosis in patients with limited-stage small cell lung cancer: a cohort study
MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis

Related Author

Heli GAO
Jin XU
Xianjun YU
CHANG Kesheng
SHAO Jin
ZHANG Qi
LIU Yifei
Ximei ZHANG

Related Institution

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Pancreatic Cancer Institute, Fudan University; Shanghai Pancreatic Cancer Institute
Department of Pathology, Wuxi Second People’s Hospital
Department of Pathology, Affiliated Hospital of Nantong University
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
Tianjin Clinical Research Center for Malignant Tumors
0